More Indictments Possible In Merck Insider Case, Judge Told
Additional charges are possible in the Manhattan U.S. attorney's probe of insider trading that preceded Merck's purchase of Pandion Therapeutics, a New York federal judge heard Wednesday, before allowing a New...To view the full article, register now.
Already a subscriber? Click here to view full article